Aerie Pharmaceuticals logo

Aerie Pharmaceuticals AERI

$ 15.25 0.0%

Quarterly report 2022-Q3
added 12-23-2023

report update icon

Country

usaUSA

IPO year

2013

Industry

Drug manufacturers

Stock Exchange

NASDAQ GLOBALSPB

CEO

Dr. Vicente Anido

Employees in the company

380

Shares

46.3 M

Market Cap[1]

$ 754 M

EBITDA (LTM)

$ -109 M

P/E (LTM)

-5.89

P/S (LTM)

6.89

EPS (LTM)

-2.59

Other stocks of industry "Drug manufacturers"

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.